SITUS JUDI MBL77 SECRETS

Not all patients with CLL involve therapy. Inspite of all new improvements, the iwCLL even now suggests watchful observation for individuals with asymptomatic condition.86 This recommendation is based on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).1